Calcein|CAS 1461-15-0|DC Chemicals

Cas No.:	1461-15-0
Chemical Name:	Calcein
Synonyms:	2,2',2'',2'''-(((3',6'-Dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-2',7'-diyl)bis(methylene))bis(azanetriyl))tetraacetic acid;Fluorescein complexon;Fluorexon;Oftasceine;Calcein;2-[[7'-[[bis(carboxymethyl)amino]methyl]-3',6'-dihydroxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-2'-yl]methyl-(carboxymethyl)amino]acetic acid;CALCEIN(RG);CALCEIN, INDICATOR FOR METAL TITRATION;Bis-[di(carboxyMethylaMinoMethyl)]flurescein sodiuM salt;Bis[N,N?bis(carboxymethyl)aminomethyl]fluorescein;Calcein [for FluoroMetric DeterMination of Ca];CarMine;Fluorescein-2,7-bis-MethylaMinodiacetic acid sodiuM salt;Fluorescein-bis(methyliminodiacetic acid);Oftasceina;Oftasceinum;Fluorescein di-(methylimino diacetic acid);Bis[N,N-bis(carboxymethyl)aminomethyl]fluorescein;CALCEINE;FLUREXONE;FLUOREXONE;oftasccine;Nsc 298193;CALCEIN, INDICATOR;V0YM2B16TS;2',7'-Bis((bis(carboxymethyl)amino)methyl)fluorescein;2,7-Bis(N,N-bis(carboxymethyl)aminomethylene)fluorescein;N,N'-(3',6'-Dihydroxyspiro(phthalid-3,9'-xanthen)-2',7'-diyldimethyl)bis(iminodiessigsaeure);Glycine, N,N'-[(3',6'-dihydroxy-3-oxo;SR-01000945252;SR-01000945252-1;SCHEMBL23435;DB11184;Fluorescein,7'-bis[[bis(carboxymethyl)amino]methyl]-;CCG-214792;Q413006;Acetic acid,6'-dihydroxy-2',7'-fluorandiyl)bis(methylenenitrilo)]tetra-;154071-48-4;2-{[(7'-{[bis(carboxymethyl)amino]methyl}-3',6'-dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthen]-2'-yl)methyl](carboxymethyl)amino}acetic acid;calcein;Fluorescein, 2',7'-bis((bis(carboxymethyl)amino)methyl)-;EINECS 215-957-1;EN300-18528188;MFCD00005049;Glycine,N'-[(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-2',7'-diyl)bis(methylene)]bis[N-(carboxymethyl)-;Glycine, N,N'-[(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-2',7'-diyl)bis(methylene)]bis[N-(carboxymethyl)-;NSC 298193;NSC-298193;2,2',2'',2'''-[(3',6'-dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-2',7'-diyl)bis(methylenenitrilo)]tetraacetic acid;Fluorexone;NS00024772;Fluorescein complex;FT-0623371;Oftasccine;Oftasceine [INN];CHEBI:51903;Oftasceina [INN-Spanish];DEGAKNSWVGKMLS-UHFFFAOYSA-N;Glycine, N,N'-((3',6'-dihydroxy-3-oxospiro(isobenzofuran-1(3H),9'-(9H)xanthene)-2',7'-diyl)bis(methylene))bis(N-(carboxymethyl)-;NSC298193;NS00069857;s5975;HY-D0040;FluorexonFluorexon;2,N-bis(carboxymethyl)aminomethylene]fluorescein;OFTASCEINE [WHO-DD];Calcein for Fluorometric Determination of Ca;UNII-V0YM2B16TS;Oftasceinum [INN-Latin];2,2,2,2-(((3,6-Dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9-xanthene]-2,7-diyl)bis(methylene))bis(azanetriyl))tetraacetic acid;CS-7704;NCI60_002494;C30H26N2O13;AKOS015903938;AS-35263;1461-15-0;CHEMBL1973733;Calcein, UltraPure Grade
SMILES:	O1C(C2=C([H])C([H])=C([H])C([H])=C2C21C1C([H])=C(C([H])([H])N(C([H])([H])C(=O)O[H])C([H])([H])C(=O)O[H])C(=C([H])C=1OC1C([H])=C(C(C([H])([H])N(C([H])([H])C(=O)O[H])C([H])([H])C(=O)O[H])=C([H])C2=1)O[H])O[H])=O
Formula:	C₃₀H₂₆N₂O₁₃
M.Wt:	622.5330
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.